A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device
Status: Terminated
Location: See all (8) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
A prospective, open-label, and multi-centered feasibility registry.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject must consent to receiving the MitraClip device
• Subject must consent, be able, and commit to wearing the Actiwatch continuously for approximately 7 months
• Subject must consent to use of their data from this registry for purposes of exploratory research and publication and presentation
Locations
United States
Arizona
Banner University Medical Center
Phoenix
California
Cedars-Sinai Medical Center
Los Angeles
Colorado
University of Colorado Hospital
Aurora
Florida
Baptist Hospital of Miami
Miami
Minnesota
Mayo Foundation for Medical Education and Research
Rochester
North Carolina
Carolinas Medical Center
Charlotte
Ohio
The Cleveland Clinic Foundation
Cleveland
Virginia
Bon Secours St Mary's Hospital
Richmond
Time Frame
Start Date: 2016-11
Completion Date: 2017-12
Participants
Target number of participants: 30
Treatments
Commercial MitraClip® patients
Patients with Degenerative Mitral Regurgitation receiving MitraClip® Device
Authors
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices